Munson Health
 
Related Information
Lewy Body Disease

Back to Document

by McCoy K

(Lewy Body Dementia; Dementia with Lewy Bodies)

 

Definition

Lewy Body Disease is a type of dementia. Dementia is the progressive loss of memory and various other mental functions, including the ability to learn, reason, and judge.
Brain Cells
Neurons
Copyright © Nucleus Medical Media, Inc.
 

Symptoms

Lewy body disease is characterized by:
 

RESOURCES

Lewy Body Dementia Association
http://www.lewybodydementia.org

National Institute of Neurological Disorders and Stroke
http://www.ninds.nih.gov

 

CANADIAN RESOURCES

Alzheimer Society
http://www.alzheimer.ca

Canadian Stroke Network
http://www.canadianstrokenetwork.ca

 

References


An introduction to Lewy body dementia. Lewy Body Disease Association website. Available at: http://lbda.org/content/intro-to-lbd . Accessed September 5, 2013.


Ballard CG, Chalmers KA, Todd C, et al. Cholinesterase inhibitors reduce cortical Abeta in dementia with Lewy bodies. Neurology. 2007;68:1726-1729.


Bouchard RW. Diagnostic criteria of dementia [review]. Can J Neurol Sci. 2007;34:(Suppl 1)S11-18.


Camicioli R, Gauthier S. Clinical trials in Parkinson's disease dementia and dementia with Lewy bodies [review]. Can J Neurol Sci. 2007;34:(Suppl 1)S109-117.


Chou KL, Borek LL, Friedman JH. The management of psychosis in movement disorder patients [review]. Expert Opin Pharmacother. 2007;8:935-943.


Dementia with Lewy bodies. EBSCO DynaMed website. Available at: http://www.ebscohost.com/dynamed.ebscohost.com/about/about-us . Updated August 9, 2013. Accessed September 5, 2013.


Dementia with Lewy bodies information page. National Institute of Neurological Disorders and Stroke website. Available at: http://www.ninds.nih.gov/disorders/dementiawithlewybodies/dementiawithlewybodies.htm . Updated June 6, 2013. Accessed September 5, 2013.


Emre M, Tsolaki M, Bonnucelli U, et al. Memantine for patients with Parkinson’s disease dementia or dementia with Lewey bodies: a randomised, double-blind, placebo controlled trial. Lancet Neurol. 2010;9(10):969-77.


Goldmann Gross R, Siderowf A, Hurtig HI. Cognitive impairment in Parkinson’s disease and dementia with Lewy bodies: a spectrum of disease. Neurosignals. 2008;16:24-34.


Jellinger KA. Formation and development of Lewy pathology: a critical update. J Neurol. 2009;256(Suppl 3):270-279.


Kemp PM, Hoffmann SA, Tossici-Bolt L, Fleming JS, Holmes C. Limitations of the HMPAO SPECT appearances of occipital lobe perfusion in the differential diagnosis of dementia with Lewy bodies. Nucl Med Commun. 2007;28:451-456.


Meeus B, et al. The genetics of dementia with Lewy bodies: what are we missing? Arch Neurol. 2012;69(9):1113-8.


Tarawneh R, Galvin JE. Distinguishing Lewy body dementias from Alzheimer’s disease. Expert Review of Neurotherapeautics. 2007;7:1499-1516.


Weintraub D, Hurtig HI. Presentation and management of psychosis in Parkinson’s disease and dementia with Lewy bodies. Am J Psychiatry. 2007;164:1491-1498.

 

Revision Information